SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: art slott who wrote (2892)1/25/1999 11:14:00 AM
From: Bruce Rozenblit  Read Replies (1) of 3725
 
Well that explains the recent appointment of a new president. Looks like Meyers and Brooks are moving over to Positron. This looks just like I had feared in an earlier post, they're just taking the same people and shuffling them around. That kind of corporate nepotism usually just breeds stagnation if not decline because there in no new blood in the mix.

Japan is broke. They are in the throws of the most serious financial crisis since the war. Yes, there are orders for Positron, but is there any money? Time will tell but I am skeptical. As far as the next 12-24 months are concerned, or until Positron turns a profit, all losses generated will impact Imat's balance sheet and drag share price down. It looks like the people on the board are deal makers. That's what they like to do. Wheel and deal! History proves it. Siemens, HeartScan, GE, Positron, all deal making. We need people that want to get into the nitty gritty of running a company. Look at the bottom line. That's the ultimate proof.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News